The function and mechanism of cervical cancer-produced NMB in the initiation and progression of PNI were then determined both in vitro and in vivo, as well as in cervical cancer patients, suggesting its potential in the prediction of PNI and the targeted therapy. This evidence concerns the gene NMB and cervical carcinoma.